Reference / Evidence
How much human evidence there is, compound by compound
429 compounds. 82 are approved in the US for at least one use, 11 more were approved and are no longer sold there, and 31 are approved only outside it. Of the rest, 52 have reached phase 3 or later, 55 phase 2 and 17 phase 1. 270 have at least one registered human trial. 168 have a trial with posted results. 166 have no published clinical trial, including 46 with nothing indexed at all. Counted from Europe PMC and trial-registry indexing, last computed November 9, 2026.
Counted from Europe PMC indexing, not read by a person; human includes reviews and cell work, original studies exclude both. A human tag comes from the indexer's subject headings and can land on analytical, commentary or lab papers that mention people; clinical trial publications is the narrower count.
| Compound | Status | Records | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0-9 | ||||||||||
| 5-Amino-1MQ | Research only | No clinical trial on record | 3 | 3 | 3 | 0 | 0 | 0 | Records → | |
| 9-ME-BC | Research only | No clinical trial on record | 10 | 3 | 1 | 0 | 0 | 0 | Records → | |
| 710GO | Investigational | No clinical trial on record | 2 | 1 | 1 | 0 | 0 | 0 | Records → | |
| A | ||||||||||
| Abaloparatide (Tymlos) | FDA-approved | Approved in the US | 433 | 262 | 126 | 37 | 25 | 11 | Records → | |
| ABBV-295 | Investigational | 5 | 5 | 0 | 0 | 4 | 0 | Records → | ||
| Ac-SDKP (TB-500 Fragment 1-4) | Research only | Phase 1 completed, no results posted · NCT01588756 | 186 | 90 | 42 | 4 | 1 | 0 | Records → | |
| ACE-031 (Ramatercept) | Research only | Phase 2 results posted · NCT01099761 | 16 | 14 | 10 | 2 | 4 | 1 | Records → | |
| ACE-083 | Investigational | Phase 2 results posted · NCT02927080 | 9 | 8 | 3 | 2 | 4 | 4 | Records → | |
| Acetyl Dipeptide-1 Cetyl Ester (Calmosensine) | Supplement or cosmetic | Published trials only 2 clinical trial publications, no phased trial registered Failed when tested for one use | 5 | 4 | 2 | 2 | 0 | 0 | Records → | |
| Acetyl Hexapeptide-1 | Supplement or cosmetic | No clinical trial on record | 3 | 2 | 2 | 0 | 0 | 0 | Records → | |
| Acetyl Hexapeptide-30 | Supplement or cosmetic | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Acetyl Hexapeptide-37 (Diffuporine) | Supplement or cosmetic | Registered study, no drug phase completed, no results posted · NCT07548424 | 2 | 2 | 0 | 0 | 2 | 0 | Records → | |
| Acetyl Hexapeptide-38 (Adifyline) | Supplement or cosmetic | No clinical trial on record | 1 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Acetyl Tetrapeptide-2 (Thymulen 4) | Supplement or cosmetic | Published trials only 1 clinical trial publication, no phased trial registered | 2 | 1 | 1 | 1 | 0 | 0 | Records → | |
| Acetyl Tetrapeptide-3 | Supplement or cosmetic | No clinical trial on record | 2 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Acetyl Tetrapeptide-5 (Eyeseryl) | Supplement or cosmetic | No clinical trial on record | 1 | 1 | 0 | 0 | 0 | 0 | Records → | |
| Acetyl Tetrapeptide-9 | Supplement or cosmetic | No clinical trial on record | 4 | 2 | 1 | 0 | 1 | 0 | Records → | |
| Acetyl Tetrapeptide-11 | Supplement or cosmetic | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Acetyl Tetrapeptide-15 (Skinasensyl) | Supplement or cosmetic | No clinical trial on record | 1 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Adalank | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Adamax | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Adamax 984 | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Adamax 1032 | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Adipotide | Research only | No clinical trial on record | 3 | 2 | 2 | 0 | 0 | 0 | Records → | |
| Adropin | Research only | Published trials only 12 clinical trial publications, no phased trial registered | 492 | 238 | 185 | 12 | 9 | 0 | 1 | Records → |
| AHK-Cu | Supplement or cosmetic | No clinical trial on record | 2 | 2 | 0 | 0 | 1 | 0 | Records → | |
| AICAR | Research only | Phase 1 completed, no results posted · NCT00559624 | 2,729 | 207 | 130 | 7 | 5 | 1 | 1 | Records → |
| Albiglutide (Tanzeum) | FDA-approved | Approved in the US, no longer sold | 325 | 244 | 76 | 32 | 42 | 25 | Records → | |
| ALT-711 | Research only | Phase 2 completed, no results posted · NCT00043836 | 161 | 66 | 26 | 9 | 13 | 0 | Records → | |
| Amycretin | Investigational | 57 | 48 | 6 | 5 | 31 | 0 | Records → | ||
| Amylin (amlintide) | Research only | 2,341 | 362 | 274 | 5 | 7 | 1 | Records → | ||
| Amylin 355 (NN9638) | Investigational | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Amyloid Beta | Research only | 140 | 90 | 54 | 10 | 1 | 0 | 1 | Records → | |
| Anamorelin | Investigational | Approved outside the US Japan | 196 | 137 | 84 | 14 | 14 | 9 | 2 | Records → |
| Anastrozole | FDA-approved | Approved in the US | 3,051 | 424 | 285 | 125 | 494 | 24 | Records → | |
| Angiotensin II (Giapreza) | FDA-approved | Approved in the US | 990 | 349 | 144 | 23 | 292 | 12 | Records → | |
| AOD-9604 | Research only | 24 | 16 | 7 | 0 | 0 | 0 | Records → | ||
| Apelin | Research only | 644 | 270 | 171 | 5 | 40 | 2 | 5 | Records → | |
| Apitegromab | FDA-approved | Approved in the US | 25 | 16 | 6 | 3 | 7 | 1 | Records → | |
| Apraglutide | Investigational | Phase 3 completed, no results posted · NCT04627025 | 40 | 34 | 13 | 7 | 12 | 4 | Records → | |
| Aprotinin | FDA-approved | Approved in the US, no longer sold | 5,547 | 372 | 244 | 52 | 33 | 6 | 1 | Records → |
| ARA-290 (Cibinetide) | Investigational | Phase 2 results posted · NCT02039687 | 82 | 38 | 18 | 5 | 4 | 1 | Records → | |
| Argireline (Acetyl Hexapeptide-8) | Supplement or cosmetic | Phase 3 completed, no results posted · NCT01381484 | 70 | 35 | 21 | 3 | 7 | 2 | Records → | |
| ASC35 | Investigational | 4 | 3 | 2 | 1 | 1 | 0 | Records → | ||
| ASC36 | Investigational | 2 | 2 | 0 | 0 | 2 | 0 | Records → | ||
| ASC37 | Investigational | No clinical trial on record | 3 | 2 | 2 | 0 | 0 | 0 | Records → | |
| AT-7687 | Investigational | 49 | 3 | 2 | 0 | 1 | 0 | Records → | ||
| Atosiban (Tractocile) | Clinical use | Approved outside the US European Union, United Kingdom, Switzerland Failed when tested for one use | 626 | 268 | 182 | 64 | 23 | 2 | Records → | |
| ATX-304 (O-304) | Research only | No clinical trial on record | 4 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Avexitide | Investigational | 119 | 91 | 26 | 11 | 57 | 13 | Records → | ||
| AZD6234 | Investigational | No clinical trial on record | 1 | 1 | 0 | 0 | 1 | 0 | Records → | |
| B | ||||||||||
| B7-33 | Research only | No clinical trial on record | 11 | 6 | 5 | 0 | 0 | 0 | Records → | |
| BAM15 | Research only | No clinical trial on record | 88 | 26 | 21 | 0 | 1 | 1 | Records → | |
| Bamzireotide navoxetan (VMT-alpha-NET) | Investigational | Published trials only 1 clinical trial publication, no phased trial registered | 10 | 6 | 5 | 1 | 0 | 0 | Records → | |
| Beinaglutide | Investigational | Approved outside the US China | 58 | 35 | 20 | 6 | 8 | 0 | Records → | |
| Berobenatide | Investigational | 23 | 23 | 0 | 0 | 23 | 1 | Records → | ||
| BI 3034701 | Investigational | 6 | 6 | 0 | 0 | 6 | 0 | Records → | ||
| Bimagrumab | Investigational | Phase 3 results posted · NCT02573467 | 98 | 74 | 32 | 17 | 18 | 10 | Records → | |
| Biotinoyl Tripeptide-1 | Supplement or cosmetic | No clinical trial on record | 4 | 2 | 0 | 0 | 2 | 0 | Records → | |
| Bivalirudin (Angiomax) | FDA-approved | Approved in the US Failed when tested for one use | 2,234 | 465 | 287 | 95 | 92 | 14 | Records → | |
| Bofanglutide (GZR18) | Investigational | 36 | 33 | 7 | 6 | 26 | 0 | Records → | ||
| Bonomarlot | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Bonothyrk | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| BPC-157 | Research only | 243 | 58 | 24 | 0 | 4 | 0 | 1 | Records → | |
| BPC-157 + TB-500 | Research only | Registered study, no drug phase results posted · NCT01775410 | 226 | 39 | 29 | 0 | 5 | 2 | Records → | |
| BPC-157 + TB-500 + Cartalax | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Bradykinin | Research only | Published trials only 15 clinical trial publications, no phased trial registered | 1,150 | 288 | 168 | 15 | 25 | 5 | Records → | |
| Brenipatide (LY3537031) | Investigational | 13 | 13 | 0 | 0 | 13 | 0 | Records → | ||
| Bronchogen | Research only | Registered study, no drug phase completed, no results posted · NCT00746759 | 34 | 9 | 7 | 0 | 1 | 0 | Records → | |
| Bulevirtide (Hepcludex) | FDA-approved | Approved in the US | 335 | 242 | 127 | 15 | 28 | 8 | Records → | |
| C | ||||||||||
| Cabergoline | FDA-approved | Approved in the US | 2,587 | 357 | 192 | 37 | 83 | 12 | 1 | Records → |
| Cagrilintide | Investigational | Phase 3 completed, no results posted · NCT05394519 | 156 | 105 | 30 | 15 | 45 | 1 | Records → | |
| CagriSema | Investigational | 126 | 86 | 21 | 12 | 34 | 1 | Records → | ||
| Calcitonin (salmon) | FDA-approved | Approved in the US | 55,964 | 205 | 65 | 11 | 230 | 10 | Records → | |
| Canvuparatide | Investigational | 10 | 8 | 2 | 2 | 5 | 0 | Records → | ||
| Carbetocin (Pabal, Duratocin) | Clinical use | Approved outside the US United Kingdom, Canada, Australia, Switzerland Failed when tested for one use | 570 | 341 | 178 | 72 | 105 | 5 | 8 | Records → |
| Cardiogen | Research only | Registered study, no drug phase completed, no results posted · NCT01424774 | 1 | 1 | 0 | 0 | 1 | 0 | Records → | |
| Carnosine | Supplement or cosmetic | Phase 4 as registered status not updated · NCT03467438 Furthest completed: phase 2 Failed when tested for one use | 3,626 | 248 | 125 | 22 | 53 | 5 | Records → | |
| Carperitide | Clinical use | Approved outside the US Japan Failed when tested for 2 uses | 310 | 235 | 192 | 43 | 3 | 0 | Records → | |
| Cartalax | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| CB4211 | Investigational | 1 | 1 | 0 | 0 | 1 | 0 | Records → | ||
| Cenderitide | Investigational | Phase 2 completed, no results posted · NCT00699712 | 73 | 40 | 15 | 2 | 12 | 0 | Records → | |
| Cerebrolysin | Clinical use | Approved outside the US 45+ countries | 710 | 242 | 140 | 56 | 43 | 3 | 9 | Records → |
| Cerebroprotein Hydrolysate | Clinical use | Approved outside the US China, India | 41 | 6 | 5 | 2 | 0 | 0 | Records → | |
| Cerluten | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Certepetide | Investigational | Phase 2 results posted · NCT05712356 | 516 | 269 | 244 | 1 | 8 | 1 | 1 | Records → |
| Cetrorelix (Cetrotide) | FDA-approved | Approved in the US | 836 | 377 | 240 | 109 | 140 | 13 | 1 | Records → |
| Chelohart | Research only | No clinical trial on record | 1 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Chitomur | Research only | Published trials only 1 clinical trial publication, no phased trial registered | 3 | 2 | 1 | 1 | 0 | 0 | Records → | |
| Chonluten | Research only | No clinical trial on record | 1 | 1 | 1 | 0 | 0 | 0 | Records → | |
| Cilengitide (EMD 121974) | Investigational | 459 | 300 | 203 | 32 | 30 | 9 | 1 | Records → | |
| CJC-1295 (no DAC) + GHRP-2 blend | Research only | No clinical trial on record | 4 | 2 | 0 | 0 | 0 | 0 | Records → | |
| CJC-1295 (no DAC) + GHRP-6 blend | Research only | Not yet indexed | Not yet indexed | |||||||
| CJC-1295 (no DAC) + Ipamorelin + GHRP-2 blend | Research only | Not yet indexed | Not yet indexed | |||||||
| CJC-1295 no DAC (Mod GRF 1-29) | Research only | No clinical trial on record | 4 | 1 | 0 | 0 | 0 | 0 | Records → | |
| CJC-1295 with DAC | Research only | 40 | 23 | 11 | 2 | 1 | 0 | Records → | ||
| Clomiphene | FDA-approved | Approved in the US | 6,232 | 381 | 204 | 49 | 263 | 13 | 16 | Records → |
| CMS-121 | Investigational | Phase 1 completed, no results posted · NCT05318040 | 14 | 6 | 4 | 0 | 1 | 0 | Records → | |
| CN-105 | Investigational | Phase 2 results posted · NCT03802396 | 32 | 15 | 7 | 4 | 6 | 2 | Records → | |
| Coremend blend (TB-500 / BPC-157 / KPV) | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Cortagen | Research only | No clinical trial on record | 15 | 3 | 2 | 0 | 0 | 0 | Records → | |
| Cortexin | Research only | Approved outside the US Russia | 184 | 114 | 103 | 28 | 0 | 0 | Records → | |
| Cosyntropin (Cortrosyn) | FDA-approved | Approved in the US Failed when tested for one use | 2,164 | 381 | 295 | 33 | 56 | 8 | Records → | |
| Crystagen | Research only | No clinical trial on record | 1 | 0 | 0 | 0 | 0 | 0 | Records → | |
| CT-388 | Investigational | 12 | 12 | 1 | 1 | 10 | 0 | Records → | ||
| Cyclosporine (Sandimmune, Restasis) | FDA-approved | Approved in the US Failed when tested for one use | 1,655 | 423 | 263 | 142 | 123 | 26 | 2 | Records → |
| D | ||||||||||
| Danegaptide (ZP1609) | Investigational | Published trials only 2 clinical trial publications, no phased trial registered Failed when tested for one use | 31 | 11 | 5 | 2 | 1 | 0 | Records → | |
| Danuglipron | Investigational | Phase 2 results posted · NCT03985293 | 78 | 55 | 27 | 5 | 20 | 11 | Records → | |
| Daptomycin (Cubicin) | FDA-approved | Approved in the US Failed when tested for one use | 5,143 | 320 | 165 | 14 | 122 | 35 | Records → | |
| Darobactin A | Research only | No clinical trial on record | 46 | 6 | 3 | 0 | 0 | 0 | Records → | |
| Dasiglucagon (Zegalogue) | FDA-approved | Approved in the US, no longer sold | 70 | 56 | 22 | 13 | 24 | 9 | Records → | |
| Davunetide (NAP) | Investigational | Phase 2 results posted · NCT00505765 | 186 | 92 | 43 | 9 | 5 | 1 | Records → | |
| Decapeptide-12 (Lumixyl) | Supplement or cosmetic | Published trials only 3 clinical trial publications, no phased trial registered | 7 | 6 | 6 | 3 | 0 | 0 | Records → | |
| Decapeptide-52 (OS-01) | Supplement or cosmetic | Published trials only 2 clinical trial publications, no phased trial registered | 10 | 4 | 4 | 2 | 0 | 0 | Records → | |
| Degarelix (Firmagon) | FDA-approved | Approved in the US | 575 | 337 | 172 | 64 | 170 | 31 | Records → | |
| Dermorphin | Research only | No clinical trial on record | 547 | 53 | 37 | 0 | 0 | 0 | Records → | |
| Desmopressin (DDAVP) | FDA-approved | Approved in the US | 6,253 | 364 | 182 | 31 | 127 | 14 | Records → | |
| Difelikefalin (Korsuva) | FDA-approved | Approved in the US Failed when tested for 2 uses | 158 | 95 | 46 | 16 | 28 | 12 | Records → | |
| Dihexa | Research only | No clinical trial on record | 18 | 8 | 3 | 0 | 0 | 0 | 1 | Records → |
| Dipeptide-2 | Supplement or cosmetic | No clinical trial on record | 174 | 25 | 23 | 0 | 0 | 0 | 1 | Records → |
| DNSP-11 | Research only | No clinical trial on record | 6 | 2 | 1 | 0 | 0 | 0 | Records → | |
| Dolcanatide (SP-333) | Investigational | 10 | 7 | 3 | 1 | 3 | 1 | Records → | ||
| DSIP (Delta Sleep-Inducing Peptide) | Research only | Published trials only 18 clinical trial publications, no phased trial registered | 481 | 103 | 83 | 18 | 0 | 0 | Records → | |
| Dulaglutide (Trulicity) | FDA-approved | Approved in the US | 1,501 | 400 | 232 | 87 | 143 | 47 | 2 | Records → |
| Dynobactin A | Research only | No clinical trial on record | 4 | 0 | 0 | 0 | 0 | 0 | Records → | |
| E | ||||||||||
| Ecnoglutide | Investigational | Approved outside the US China | 34 | 29 | 7 | 6 | 17 | 0 | Records → | |
| Efinopegdutide | Investigational | Phase 2 results posted · NCT03486392 | 25 | 24 | 3 | 3 | 15 | 5 | Records → | |
| Efmedaglutide Alfa (TG103) | Investigational | Phase 3 completed, no results posted · NCT05997576 | 15 | 14 | 2 | 2 | 11 | 0 | Records → | |
| Efpeglenatide | Clinical use | Approved outside the US South Korea Failed when tested for one use | 73 | 46 | 28 | 12 | 5 | 5 | Records → | |
| Efsubaglutide Alfa | Clinical use | Approved outside the US China | 31 | 22 | 14 | 11 | 8 | 0 | Records → | |
| Elabela | Research only | Registered study, no drug phase or later completed, no results posted · NCT01691066 | 879 | 286 | 117 | 0 | 541 | 23 | Records → | |
| Eloralintide | Investigational | 35 | 32 | 3 | 3 | 25 | 1 | Records → | ||
| Enclomiphene | Clinical use | Phase 3 or later results posted · NCT01532414 | 411 | 135 | 26 | 7 | 263 | 13 | Records → | |
| ENDO-205 | Investigational | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Endoluten | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Enfuvirtide (Fuzeon) | FDA-approved | Approved in the US, no longer sold | 1,296 | 420 | 206 | 29 | 54 | 16 | Records → | |
| Enlicitide (Lipfendra) | FDA-approved | Approved in the US | 91 | 66 | 9 | 5 | 34 | 8 | Records → | |
| Epitalon | Research only | Published trials only 7 clinical trial publications, no phased trial registered | 173 | 58 | 33 | 7 | 1 | 0 | Records → | |
| EPO (Erythropoietin) | FDA-approved | Approved in the US | 7,319 | 412 | 255 | 92 | 1,055 | 33 | 1 | Records → |
| Eptifibatide | FDA-approved | Approved in the US Failed when tested for one use | 1,251 | 370 | 255 | 102 | 35 | 14 | Records → | |
| Etelcalcetide (Parsabiv) | FDA-approved | Approved in the US | 185 | 130 | 82 | 24 | 23 | 16 | Records → | |
| Exenatide (Byetta / Bydureon) | FDA-approved | Approved in the US | 5,604 | 338 | 171 | 63 | 380 | 34 | 1 | Records → |
| F | ||||||||||
| FLGR242 | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Follistatin (FST-344) | Research only | Phase 1 completed, no results posted · NCT01519349 | 3,251 | 258 | 166 | 15 | 15 | 1 | 1 | Records → |
| FOXO4-DRI | Research only | No clinical trial on record | 17 | 8 | 5 | 0 | 0 | 0 | Records → | |
| G | ||||||||||
| Ganirelix (Orgalutran) | FDA-approved | Approved in the US | 322 | 263 | 135 | 62 | 105 | 14 | 1 | Records → |
| GB-115 | Research only | 28 | 6 | 3 | 0 | 2 | 0 | Records → | ||
| GDF-8 (Myostatin) | Research only | 5,114 | 254 | 144 | 16 | 35 | 5 | Records → | ||
| GDF-11 | Research only | Published trials only 4 clinical trial publications, no phased trial registered | 810 | 213 | 140 | 4 | 2 | 0 | 3 | Records → |
| GHK (copper-free) | Supplement or cosmetic | Published trials only 2 clinical trial publications, no phased trial registered | 323 | 85 | 49 | 2 | 4 | 0 | Records → | |
| GHK-Cu | Supplement or cosmetic | 207 | 62 | 34 | 1 | 5 | 0 | Records → | ||
| Ghrelin (lenomorelin) | Investigational | 732 | 319 | 188 | 120 | 241 | 11 | Records → | ||
| GHRP-1 | Research only | 65 | 24 | 17 | 4 | 1 | 0 | Records → | ||
| GHRP-2 | Research only | Published trials only 56 clinical trial publications, no phased trial registered | 244 | 140 | 115 | 56 | 0 | 0 | Records → | |
| GHRP-3 | Research only | No clinical trial on record | 5 | 3 | 2 | 0 | 1 | 0 | Records → | |
| GHRP-4 | Research only | No clinical trial on record | 6 | 5 | 5 | 0 | 0 | 0 | Records → | |
| GHRP-5 | Research only | No clinical trial on record | 9 | 6 | 6 | 0 | 0 | 0 | Records → | |
| GHRP-6 | Research only | Published trials only 29 clinical trial publications, no phased trial registered | 733 | 164 | 134 | 29 | 0 | 0 | Records → | |
| Glandokort | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Glepaglutide (Zeydovio) | Investigational | 44 | 31 | 14 | 10 | 11 | 2 | Records → | ||
| GLOW blend | Research only | No clinical trial on record | 9 | 4 | 0 | 0 | 0 | 0 | Records → | |
| GLOW Plus blend | Research only | Not yet indexed | Not yet indexed | |||||||
| Glucagon (Baqsimi, Gvoke) | FDA-approved | Approved in the US | 1,651 | 183 | 66 | 24 | 1,530 | 15 | Records → | |
| Glutathione | Supplement or cosmetic | Phase 2 results posted · NCT03020719 | 270 | 118 | 76 | 32 | 20 | 2 | Records → | |
| Gonadorelin (GnRH) | Clinical use | Approved in the US, no longer sold | 1,511 | 215 | 89 | 28 | 1,164 | 30 | Records → | |
| Goserelin (Zoladex) | FDA-approved | Approved in the US | 1,920 | 446 | 302 | 156 | 417 | 21 | Records → | |
| Gotratix | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| GW501516 (Cardarine) | Research only | Phase 2 completed, no results posted · NCT00158899 | 352 | 176 | 101 | 6 | 3 | 0 | 6 | Records → |
| GZC8072 | Investigational | 1 | 1 | 0 | 0 | 1 | 0 | Records → | ||
| H | ||||||||||
| HCG (Human Chorionic Gonadotropin) | Clinical use | Approved in the US | 17,847 | 353 | 205 | 10 | 412 | 15 | Records → | |
| HCXT-2001 | Investigational | 1 | 1 | 0 | 0 | 1 | 0 | Records → | ||
| Hexapeptide-9 | Supplement or cosmetic | Published trials only 1 clinical trial publication, no phased trial registered | 8 | 3 | 2 | 1 | 0 | 0 | Records → | |
| Hexapeptide-10 (Serilesine) | Supplement or cosmetic | No clinical trial on record | 2 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Hexapeptide-11 | Supplement or cosmetic | No clinical trial on record | 10 | 6 | 3 | 0 | 0 | 0 | Records → | |
| Hexarelin | Research only | Published trials only 58 clinical trial publications, no phased trial registered | 329 | 169 | 138 | 58 | 0 | 0 | Records → | |
| HGH (Somatropin) | Clinical use | Approved in the US | 7,003 | 423 | 247 | 58 | 823 | 21 | 1 | Records → |
| HGH Fragment 176-191 | Research only | No clinical trial on record | 3 | 2 | 1 | 0 | 0 | 0 | Records → | |
| Histrelin (Supprelin LA) | FDA-approved | Approved in the US | 153 | 81 | 50 | 8 | 15 | 2 | Records → | |
| HMG (Menotropin) | Clinical use | Approved in the US | 1,726 | 453 | 314 | 73 | 171 | 10 | 2 | Records → |
| Humanin | Research only | Published trials only 7 clinical trial publications, no phased trial registered | 594 | 258 | 157 | 7 | 3 | 0 | 2 | Records → |
| I | ||||||||||
| Icatibant (Firazyr) | FDA-approved | Approved in the US Failed when tested for one use | 2,055 | 220 | 131 | 28 | 33 | 15 | Records → | |
| Icotrokinra (Icotyde) | FDA-approved | Approved in the US | 60 | 36 | 11 | 8 | 16 | 8 | Records → | |
| IGF-1 DES | Research only | No clinical trial on record | 210 | 91 | 59 | 0 | 0 | 0 | Records → | |
| IGF-1 LR3 | Research only | No clinical trial on record | 92 | 28 | 18 | 0 | 0 | 0 | Records → | |
| Imunofan | Research only | Approved outside the US Russia | 47 | 25 | 22 | 4 | 0 | 0 | Records → | |
| Insulin Efsitora Alfa (Onswik) | FDA-approved | Approved in the US Failed when tested for one use | 68 | 41 | 19 | 13 | 5 | 5 | Records → | |
| Insulin Icodec (Awiqli) | FDA-approved | Approved in the US | 218 | 151 | 72 | 38 | 40 | 14 | Records → | |
| Ipamorelin | Research only | Phase 2 completed, no results posted · NCT01280344 | 67 | 27 | 16 | 2 | 3 | 0 | Records → | |
| Ipamorelin + CJC-1295 (no DAC) blend | Research only | No clinical trial on record | 15 | 7 | 0 | 0 | 0 | 0 | Records → | |
| Irisin | Research only | Published trials only 14 clinical trial publications, no phased trial registered | 3,188 | 341 | 158 | 14 | 84 | 1 | Records → | |
| K | ||||||||||
| KAI-4729 | Investigational | 5 | 5 | 0 | 0 | 5 | 0 | Records → | ||
| Kisspeptin | Research only | Phase 3 completed, no results posted · NCT03286517 | 493 | 188 | 128 | 36 | 21 | 6 | Records → | |
| Klotho | Research only | Published trials only 1 clinical trial publication, no phased trial registered | 119 | 57 | 30 | 1 | 0 | 0 | Records → | |
| KLOW blend | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| KPV | Research only | No clinical trial on record | 207 | 50 | 32 | 0 | 0 | 0 | Records → | |
| L | ||||||||||
| L-Carnitine (Levocarnitine) | FDA-approved | Approved in the US | 8,914 | 303 | 128 | 33 | 319 | 7 | 3 | Records → |
| Lacripep | Investigational | 8 | 6 | 2 | 1 | 3 | 0 | Records → | ||
| Lanreotide (Somatuline Depot) | FDA-approved | Approved in the US | 1,394 | 426 | 245 | 78 | 118 | 28 | Records → | |
| Lapemelanotide zapixetan (VMT01) | Investigational | No clinical trial on record | 3 | 2 | 2 | 0 | 0 | 0 | Records → | |
| Larazotide | Investigational | Phase 3 results posted · NCT00925301 | 84 | 63 | 18 | 4 | 31 | 12 | Records → | |
| LEAP2 | Research only | Phase 1 completed, no results posted · NCT07171723 | 407 | 137 | 101 | 15 | 10 | 0 | Records → | |
| Letrozole | FDA-approved | Approved in the US | 6,180 | 359 | 221 | 109 | 910 | 26 | 1 | Records → |
| Leuphasyl (Pentapeptide-18) | Supplement or cosmetic | No clinical trial on record | 7 | 6 | 4 | 0 | 0 | 0 | Records → | |
| Leuprolide (Lupron) | FDA-approved | Approved in the US | 3,746 | 364 | 228 | 80 | 520 | 44 | Records → | |
| Libidon | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Linaclotide (Linzess) | FDA-approved | Approved in the US | 533 | 330 | 147 | 53 | 60 | 24 | 1 | Records → |
| Lipo-C (MIC blend) | Clinical use | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Lipopeptide | Supplement or cosmetic | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Liraglutide | FDA-approved | Approved in the US | 6,292 | 342 | 175 | 67 | 520 | 28 | 1 | Records → |
| Livagen | Research only | No clinical trial on record | 24 | 14 | 10 | 0 | 0 | 0 | Records → | |
| Lixisenatide (Adlyxin) | FDA-approved | Approved in the US, no longer sold | 786 | 377 | 183 | 90 | 77 | 27 | 2 | Records → |
| LL-37 | Research only | 4,592 | 342 | 197 | 3 | 34 | 7 | 1 | Records → | |
| Lonapegsomatropin (Skytrofa) | FDA-approved | Approved in the US | 295,587 | 226 | 196 | 20 | 8 | 2 | Records → | |
| Lucicebtide (ST101) | Investigational | Phase 2 completed, no results posted · NCT00842673 | 12 | 9 | 2 | 0 | 5 | 0 | Records → | |
| Lumekefamide (Tafalgin) | Clinical use | Approved outside the US Russia | 4 | 2 | 1 | 0 | 1 | 0 | Records → | |
| Lutetium-177 dotatate (Lutathera) | FDA-approved | Approved in the US | 774 | 385 | 218 | 25 | 107 | 7 | 1 | Records → |
| Lutetium-177 edotreotide (ITM-11) | Investigational | Published trials only 41 clinical trial publications, no phased trial registered | 972 | 333 | 295 | 41 | 0 | 0 | Records → | |
| M | ||||||||||
| Macimorelin (Macrilen) | FDA-approved | Approved in the US | 44 | 32 | 18 | 4 | 6 | 3 | Records → | |
| Macupatide (LY3532226) | Investigational | 5 | 5 | 1 | 1 | 4 | 0 | Records → | ||
| MariTide (maridebart cafraglutide) | Investigational | 61 | 46 | 5 | 2 | 32 | 2 | Records → | ||
| Matrixyl (Palmitoyl Pentapeptide-4) | Supplement or cosmetic | Published trials only 3 clinical trial publications, no phased trial registered | 57 | 26 | 16 | 3 | 0 | 0 | Records → | |
| Mazdutide | Investigational | Approved outside the US China | 112 | 84 | 15 | 10 | 46 | 1 | Records → | |
| MBX 4291 | Investigational | 1 | 1 | 0 | 0 | 1 | 0 | Records → | ||
| Mecasermin (Increlex) | FDA-approved | Approved in the US Failed when tested for 3 uses | 110 | 84 | 30 | 1 | 37 | 20 | Records → | |
| Melanotan I (Afamelanotide) | Research only | Approved in the US as an implant only | 146 | 104 | 49 | 12 | 23 | 12 | Records → | |
| Melanotan II | Research only | 205 | 49 | 35 | 4 | 1 | 0 | Records → | ||
| Melanotan III | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| MENTSH | Research only | No clinical trial on record | 3 | 2 | 2 | 0 | 0 | 0 | Records → | |
| Methylene Blue | Supplement or cosmetic | Approved in the US into a vein only | 4,414 | 357 | 201 | 43 | 345 | 14 | 1 | Records → |
| Metreleptin (Myalept) | FDA-approved | Approved in the US Failed when tested for one use | 356 | 261 | 167 | 59 | 39 | 25 | Records → | |
| MGF (Mechano Growth Factor) | Research only | Published trials only 11 clinical trial publications, no phased trial registered | 378 | 238 | 81 | 11 | 108 | 31 | 1 | Records → |
| MIF-1 | Research only | Published trials only 1 clinical trial publication, no phased trial registered | 476 | 91 | 70 | 1 | 1 | 1 | Records → | |
| Mifamurtide (Mepact) | Clinical use | Approved outside the US European Union, United Kingdom | 235 | 125 | 69 | 28 | 13 | 1 | Records → | |
| Mifomelatide | Investigational | 13 | 6 | 3 | 0 | 3 | 0 | Records → | ||
| MitoPrime blend (NAD+ / MOTS-c / 5-Amino-1MQ) | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| MK-677 (Ibutamoren) | Research only | Phase 2 results posted · NCT05364684 | 134 | 80 | 48 | 19 | 8 | 2 | Records → | |
| MK-777 | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| MOTS-c | Research only | 284 | 153 | 89 | 5 | 5 | 0 | 1 | Records → | |
| Myristoyl Hexapeptide-16 | Supplement or cosmetic | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Myristoyl Pentapeptide-17 | Supplement or cosmetic | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| N | ||||||||||
| N-Acetyl Epitalon Amidate | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| N-Acetyl Selank | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| N-Acetyl Selank Amidate | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| N-Acetyl Semax | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| N-Acetyl Semax Amidate | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| NA-931 | Investigational | Phase 2 completed, no results posted · NCT06564753 | 6 | 3 | 0 | 0 | 3 | 0 | Records → | |
| NAD+ | Clinical use | Published trials only 6 clinical trial publications, no phased trial registered | 151 | 70 | 33 | 6 | 13 | 1 | Records → | |
| Nafarelin (Synarel) | FDA-approved | Approved in the US | 294 | 232 | 193 | 83 | 12 | 0 | 1 | Records → |
| Navepegritide (Yuviwel) | FDA-approved | Approved in the US | 27 | 16 | 5 | 4 | 8 | 2 | Records → | |
| Nelipepimut-S (NeuVax) | Investigational | 34 | 29 | 16 | 13 | 4 | 3 | Records → | ||
| Nerinetide (NA-1) | Investigational | 160 | 74 | 52 | 26 | 3 | 2 | 2 | Records → | |
| Nesiritide (Natrecor) | FDA-approved | Approved in the US, no longer sold Failed when tested for 3 uses | 861 | 462 | 232 | 90 | 289 | 10 | Records → | |
| Neuropeptide Y | Research only | 397 | 107 | 71 | 6 | 4 | 0 | Records → | ||
| Neurotensin | Research only | 1,030 | 250 | 180 | 3 | 17 | 1 | Records → | ||
| Nicotinamide Riboside (NR) | Supplement or cosmetic | Phase 4 as registered or later results posted · NCT03151707 | 1,193 | 291 | 121 | 30 | 127 | 13 | Records → | |
| Nisotirostide (LY3457263) | Investigational | No clinical trial on record Failed when tested for one use | 1 | 0 | 0 | 0 | 0 | 0 | Records → | |
| NMN | Supplement or cosmetic | 1,679 | 214 | 115 | 15 | 38 | 2 | Records → | ||
| NN9662 (Triple) | Investigational | 6 | 6 | 0 | 0 | 6 | 0 | Records → | ||
| Nonapeptide-1 (Melanostatine-5) | Supplement or cosmetic | Published trials only 1 clinical trial publication, no phased trial registered | 26 | 3 | 3 | 1 | 0 | 0 | Records → | |
| Noopept (Omberacetam) | Research only | Approved outside the US Russia | 113 | 28 | 20 | 3 | 0 | 0 | 2 | Records → |
| Nuzefatide Pevedotin (BT5528) | Investigational | 8 | 8 | 4 | 1 | 2 | 0 | Records → | ||
| O | ||||||||||
| Octapeptide-45 | Supplement or cosmetic | Published trials only 3 clinical trial publications, no phased trial registered | 5 | 4 | 4 | 3 | 0 | 0 | Records → | |
| Octreotide (Sandostatin) | FDA-approved | Approved in the US Failed when tested for one use | 10,111 | 373 | 212 | 44 | 328 | 16 | Records → | |
| Olatorepatide (HS-20094) | Investigational | Phase 3 completed, no results posted · NCT06839664 | 12 | 12 | 0 | 0 | 12 | 0 | Records → | |
| Oligopeptide-1 (EGF) | Supplement or cosmetic | Phase 3 completed, no results posted · NCT01629199 | 98,199 | 338 | 235 | 53 | 16 | 0 | Records → | |
| Oligopeptide-68 | Supplement or cosmetic | Published trials only 7 clinical trial publications, no phased trial registered | 235 | 80 | 72 | 7 | 3 | 0 | Records → | |
| Omiganan (MBI-226) | Investigational | 73 | 52 | 23 | 6 | 18 | 5 | Records → | ||
| Orexin A | Research only | Published trials only 7 clinical trial publications, no phased trial registered | 7,368 | 288 | 121 | 7 | 80 | 17 | 1 | Records → |
| Orforglipron | FDA-approved | Approved in the US | 215 | 139 | 38 | 21 | 54 | 29 | Records → | |
| ORJ-001 (NP-201) | Investigational | 2 | 2 | 0 | 0 | 2 | 0 | Records → | ||
| Ovagen | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Oxyntomodulin (OXM) | Research only | Phase 1 results posted · NCT01373450 | 536 | 204 | 104 | 31 | 10 | 3 | Records → | |
| Oxytocin | Clinical use | Approved in the US | 2,390 | 402 | 238 | 155 | 274 | 32 | Records → | |
| P | ||||||||||
| P-15 (Osteogenic Cell Binding Peptide) | Clinical use | Approved outside the US European Union, Australia, Canada | 1,204 | 91 | 79 | 6 | 0 | 0 | Records → | |
| P7C3 | Research only | No clinical trial on record | 93 | 21 | 12 | 0 | 0 | 0 | Records → | |
| P11-4 (Oligopeptide-104) | Supplement or cosmetic | Approved outside the US European Union, Switzerland | 166 | 96 | 40 | 15 | 32 | 1 | Records → | |
| P21 | Research only | No clinical trial on record | 8 | 2 | 1 | 0 | 0 | 0 | Records → | |
| P110 | Research only | No clinical trial on record | 53 | 27 | 15 | 0 | 0 | 0 | Records → | |
| P140 (forigerimod) | Investigational | 42 | 28 | 13 | 3 | 4 | 3 | Records → | ||
| Pal-AHK | Supplement or cosmetic | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Palmitoyl Hexapeptide-12 | Supplement or cosmetic | No clinical trial on record | 2 | 1 | 1 | 0 | 0 | 0 | Records → | |
| Palmitoyl Tetrapeptide-7 | Supplement or cosmetic | Published trials only 1 clinical trial publication, no phased trial registered | 14 | 4 | 3 | 1 | 1 | 0 | Records → | |
| Palmitoyl Tripeptide-1 | Supplement or cosmetic | No clinical trial on record | 7 | 3 | 2 | 0 | 0 | 0 | Records → | |
| Palmitoyl Tripeptide-5 | Supplement or cosmetic | Published trials only 1 clinical trial publication, no phased trial registered | 8 | 4 | 2 | 1 | 2 | 0 | Records → | |
| Palmitoyl Tripeptide-8 | Supplement or cosmetic | No clinical trial on record | 6 | 2 | 2 | 0 | 0 | 0 | Records → | |
| Palmitoyl Tripeptide-38 | Supplement or cosmetic | Published trials only 1 clinical trial publication, no phased trial registered | 5 | 4 | 2 | 1 | 1 | 0 | Records → | |
| Palopegteriparatide (Yorvipath) | FDA-approved | Approved in the US | 76 | 43 | 22 | 11 | 11 | 2 | Records → | |
| Pancragen | Research only | No clinical trial on record | 20 | 4 | 1 | 0 | 0 | 0 | Records → | |
| Pasireotide (Signifor) | FDA-approved | Approved in the US Failed when tested for one use | 947 | 413 | 225 | 69 | 87 | 40 | Records → | |
| PDA (Pentadeca Arginate) | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| PE-22-28 | Research only | No clinical trial on record | 1 | 0 | 0 | 0 | 0 | 0 | Records → | |
| PEG-MGF | Research only | No clinical trial on record | 3 | 1 | 0 | 0 | 0 | 0 | Records → | |
| Pegcetacoplan (Empaveli, Syfovre) | FDA-approved | Approved in the US Failed when tested for one use | 381 | 229 | 120 | 39 | 38 | 16 | Records → | |
| Pegloxenatide (Fulaimei) | Clinical use | Approved outside the US China Failed when tested for one use | 60 | 38 | 19 | 12 | 13 | 0 | Records → | |
| Pegtarazimod (RLS-0071) | Investigational | 32 | 9 | 3 | 0 | 6 | 0 | Records → | ||
| Pemvidutide | Investigational | 36 | 25 | 6 | 3 | 16 | 5 | Records → | ||
| Pentagastrin (Peptavlon) | FDA-approved | Approved in the US, no longer sold | 4,120 | 272 | 249 | 68 | 7 | 0 | Records → | |
| Pentosan Polysulfate (PPS) | Clinical use | Approved in the US | 800 | 293 | 198 | 46 | 19 | 2 | Records → | |
| Peptide YY | Research only | 397 | 193 | 116 | 33 | 43 | 1 | Records → | ||
| Petrelintide | Investigational | 21 | 20 | 4 | 2 | 12 | 0 | Records → | ||
| Pexiganan | Investigational | 172 | 60 | 42 | 1 | 4 | 2 | Records → | ||
| PF-08653945 (MET-233i) | Investigational | 6 | 6 | 0 | 0 | 4 | 0 | Records → | ||
| Phenibut | Research only | Approved outside the US Russia | 304 | 114 | 98 | 14 | 0 | 0 | Records → | |
| Pielotax | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Pinealon | Research only | Published trials only 1 clinical trial publication, no phased trial registered | 17 | 8 | 5 | 1 | 0 | 0 | Records → | |
| PL8177 | Investigational | 6 | 4 | 3 | 0 | 1 | 0 | Records → | ||
| PL9643 | Investigational | 4 | 4 | 1 | 1 | 2 | 0 | Records → | ||
| Plecanatide (Trulance) | FDA-approved | Approved in the US | 125 | 91 | 37 | 12 | 15 | 11 | Records → | |
| PN-881 | Investigational | Phase 1 completed, no results posted · NCT07153146 | 1 | 1 | 0 | 0 | 1 | 0 | Records → | |
| PNC-27 | Research only | No clinical trial on record | 25 | 16 | 13 | 0 | 0 | 0 | 1 | Records → |
| PNC-28 | Research only | No clinical trial on record | 7 | 5 | 4 | 0 | 0 | 0 | Records → | |
| Poterepatide (HDM1005) | Investigational | 14 | 14 | 1 | 0 | 13 | 0 | Records → | ||
| Pramlintide | FDA-approved | Approved in the US, no longer sold | 556 | 354 | 167 | 77 | 65 | 15 | 1 | Records → |
| Progeline (Trifluoroacetyl Tripeptide-2) | Supplement or cosmetic | No clinical trial on record | 1 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Prostamax | Research only | No clinical trial on record | 7 | 4 | 1 | 0 | 0 | 0 | Records → | |
| PT-141 (Bremelanotide) | FDA-approved | Approved in the US | 134 | 82 | 29 | 15 | 10 | 4 | 1 | Records → |
| PT-142 | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| PT00114 | Investigational | No clinical trial on record | 44 | 9 | 3 | 0 | 0 | 0 | Records → | |
| PTD-DBM | Research only | No clinical trial on record | 4 | 3 | 2 | 0 | 0 | 0 | Records → | |
| PXL01 (ensereptide) | Investigational | 10 | 6 | 2 | 1 | 2 | 1 | Records → | ||
| PYY1875 (NNC0165-1875) | Investigational | 4 | 4 | 2 | 1 | 2 | 1 | Records → | ||
| R | ||||||||||
| RADA16 (PuraStat) | Clinical use | Approved outside the US European Union, Japan, Australia, Canada, Brazil, Mexico, Indonesia, Thailand, Colombia | 438 | 182 | 108 | 6 | 25 | 3 | Records → | |
| RAY1225 (Bilpatide) | Investigational | 13 | 12 | 0 | 0 | 12 | 0 | Records → | ||
| Redasemtide | Investigational | 2 | 1 | 0 | 0 | 1 | 0 | Records → | ||
| Relamorelin | Investigational | 62 | 48 | 20 | 10 | 13 | 6 | Records → | ||
| Reltecimod (AB103) | Investigational | 32 | 14 | 6 | 4 | 4 | 4 | Records → | ||
| Retatrutide | Investigational | Phase 3 completed, no results posted · NCT05882045 | 291 | 170 | 45 | 13 | 34 | 2 | Records → | |
| Retatrutide + Cagrilintide blend | Research only | No clinical trial on record | 23 | 13 | 1 | 0 | 0 | 0 | Records → | |
| Retinalamin | Research only | Approved outside the US Russia | 27 | 19 | 17 | 4 | 0 | 0 | Records → | |
| Ribupatide | Investigational | Phase 3 completed, no results posted · NCT06396429 | 41 | 41 | 1 | 1 | 40 | 0 | Records → | |
| Rindopepimut (CDX-110) | Investigational | 50 | 31 | 14 | 3 | 6 | 0 | 1 | Records → | |
| Romiplostim (Nplate) | FDA-approved | Approved in the US Failed when tested for one use | 1,046 | 413 | 223 | 62 | 124 | 28 | Records → | |
| RP001v63 | Investigational | No clinical trial on record | 5 | 4 | 3 | 0 | 0 | 0 | Records → | |
| Rusfertide (Mimrylo) | FDA-approved | Approved in the US | 33 | 23 | 9 | 6 | 10 | 2 | Records → | |
| RYZ101 (actinium-225 dotatate) | Investigational | 20 | 15 | 7 | 1 | 5 | 0 | Records → | ||
| S | ||||||||||
| Secretin (ChiRhoStim) | FDA-approved | Approved in the US Failed when tested for 2 uses | 1,772 | 423 | 287 | 32 | 53 | 8 | Records → | |
| Selank | Research only | Approved outside the US Russia | 72 | 16 | 10 | 3 | 2 | 0 | Records → | |
| Semaglutide | FDA-approved | Approved in the US | 6,820 | 364 | 194 | 78 | 804 | 14 | 1 | Records → |
| Semax | Research only | Approved outside the US Russia | 402 | 107 | 80 | 26 | 0 | 0 | Records → | |
| Semax + Selank blend | Research only | No clinical trial on record | 12 | 4 | 2 | 0 | 0 | 0 | Records → | |
| Serelaxin (RLX030) | Investigational | 340 | 236 | 142 | 52 | 17 | 10 | Records → | ||
| Sermorelin | Clinical use | Approved in the US, no longer sold | 237 | 107 | 63 | 13 | 27 | 11 | Records → | |
| Sermorelin + GHRP-2 blend | Research only | Not yet indexed | Not yet indexed | |||||||
| Sermorelin + GHRP-6 blend | Research only | Not yet indexed | Not yet indexed | |||||||
| Sermorelin + Ipamorelin blend | Research only | No clinical trial on record | 9 | 5 | 0 | 0 | 0 | 0 | Records → | |
| Setmelanotide (Imcivree) | FDA-approved | Approved in the US | 263 | 148 | 70 | 16 | 27 | 14 | Records → | |
| SHLP2 | Research only | No clinical trial on record | 29 | 16 | 8 | 0 | 0 | 0 | Records → | |
| SHLP6 | Research only | No clinical trial on record | 11 | 6 | 3 | 0 | 0 | 0 | Records → | |
| Sigumir | Research only | Published trials only 1 clinical trial publication, no phased trial registered | 3 | 3 | 2 | 1 | 0 | 0 | Records → | |
| Sincalide (Kinevac) | FDA-approved | Approved in the US Failed when tested for one use | 135 | 98 | 78 | 8 | 10 | 3 | Records → | |
| SLU-PP-332 | Research only | No clinical trial on record | 12 | 6 | 5 | 0 | 0 | 0 | Records → | |
| SNAP-8 (Acetyl Octapeptide-3) | Supplement or cosmetic | Published trials only 1 clinical trial publication, no phased trial registered | 2 | 1 | 1 | 1 | 0 | 0 | Records → | |
| Somapacitan (Sogroya) | FDA-approved | Approved in the US | 140 | 86 | 43 | 27 | 21 | 8 | Records → | |
| Somatostatin | Clinical use | Approved outside the US Spain, Singapore, Germany, France, Italy, Poland, Austria, Belgium, Cyprus, Czech Republic | 1,313 | 186 | 133 | 27 | 10 | 1 | Records → | |
| Somatrogon (Ngenla) | FDA-approved | Approved in the US | 99 | 58 | 33 | 12 | 9 | 3 | Records → | |
| Sovateltide | Clinical use | Approved outside the US India Failed when tested for one use | 421 | 77 | 34 | 3 | 11 | 0 | Records → | |
| Spexin | Research only | Published trials only 7 clinical trial publications, no phased trial registered | 280 | 120 | 90 | 7 | 1 | 0 | Records → | |
| Splenopentin | Research only | Published trials only 3 clinical trial publications, no phased trial registered | 41 | 18 | 11 | 3 | 0 | 0 | Records → | |
| SR9009 (Stenabolic) | Research only | No clinical trial on record | 148 | 44 | 35 | 0 | 0 | 0 | 4 | Records → |
| SS-31 (Elamipretide) | FDA-approved | Approved in the US Failed when tested for one use | 514 | 188 | 81 | 15 | 30 | 14 | 1 | Records → |
| ST316 | Investigational | 2 | 2 | 0 | 0 | 2 | 0 | Records → | ||
| Stamakort | Research only | No clinical trial on record | 2 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Substance P | Research only | Published trials only 12 clinical trial publications, no phased trial registered | 102 | 64 | 35 | 12 | 4 | 0 | Records → | |
| Suprefort | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Surotomycin | Investigational | 56 | 40 | 16 | 5 | 4 | 2 | Records → | ||
| Survodutide | Investigational | Phase 3 completed, no results posted · NCT06066515 | 135 | 92 | 23 | 12 | 36 | 3 | Records → | |
| Svetinorm | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| SYN-AKE | Supplement or cosmetic | No clinical trial on record | 5 | 2 | 2 | 0 | 0 | 0 | Records → | |
| T | ||||||||||
| Taltirelin (Ceredist) | Investigational | Approved outside the US Japan, South Korea | 94 | 20 | 16 | 2 | 1 | 0 | Records → | |
| Tamoxifen | FDA-approved | Approved in the US | 29,824 | 388 | 251 | 51 | 687 | 22 | Records → | |
| Taxorest | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| TB-500 / Thymosin Beta-4 | Research only | 56 | 26 | 15 | 1 | 1 | 0 | Records → | ||
| Teduglutide (Gattex) | FDA-approved | Approved in the US | 422 | 291 | 172 | 29 | 50 | 20 | Records → | |
| Teixobactin | Research only | No clinical trial on record Failed when tested for one use | 124 | 28 | 14 | 0 | 0 | 0 | Records → | |
| Teriparatide (Forteo) | FDA-approved | Approved in the US | 5,050 | 370 | 203 | 60 | 196 | 38 | Records → | |
| Terlipressin (Terlivaz) | FDA-approved | Approved in the US | 1,371 | 416 | 219 | 85 | 116 | 6 | Records → | |
| Tertomotide (GV1001) | Investigational | 104 | 74 | 40 | 11 | 18 | 1 | Records → | ||
| Tesamorelin | FDA-approved | Approved in the US | 131 | 98 | 47 | 24 | 24 | 10 | Records → | |
| Tesamorelin + Ipamorelin blend | Research only | No clinical trial on record | 9 | 6 | 0 | 0 | 0 | 0 | Records → | |
| Tesofensine | Investigational | Phase 2 results posted · NCT02737891 | 68 | 48 | 20 | 11 | 14 | 5 | Records → | |
| Testagen | Research only | 12 | 2 | 1 | 0 | 1 | 0 | Records → | ||
| Testoluten | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Tetrapeptide-21 | Supplement or cosmetic | No clinical trial on record | 4 | 2 | 2 | 0 | 0 | 0 | Records → | |
| Thymalin | Research only | Published trials only 12 clinical trial publications, no phased trial registered | 243 | 156 | 145 | 12 | 0 | 0 | Records → | |
| Thymogen | Research only | Approved outside the US Russia | 110 | 49 | 40 | 7 | 1 | 0 | Records → | |
| Thymopentin (TP-5) | Clinical use | Approved outside the US Italy, China | 516 | 219 | 164 | 73 | 10 | 0 | Records → | |
| Thymosin Alpha-1 | Clinical use | Approved outside the US 30+ countries | 876 | 273 | 143 | 40 | 67 | 2 | Records → | |
| Thymosin Beta-15 | Research only | No clinical trial on record | 42 | 12 | 11 | 0 | 0 | 0 | Records → | |
| Thymulin | Research only | Published trials only 7 clinical trial publications, no phased trial registered | 581 | 183 | 117 | 7 | 0 | 0 | 1 | Records → |
| Thyreogen | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Tirzepatide | FDA-approved | Approved in the US | 3,097 | 363 | 180 | 62 | 313 | 17 | Records → | |
| Toremifene | FDA-approved | Approved in the US | 887 | 365 | 241 | 77 | 41 | 2 | Records → | |
| TP508 (rusalatide) | Investigational | 51 | 24 | 7 | 1 | 1 | 0 | Records → | ||
| Trevogrumab | Investigational | Phase 2 completed, no results posted · NCT01963598 | 15 | 12 | 1 | 0 | 8 | 0 | Records → | |
| TRH (Protirelin) | FDA-approved | Approved in the US, no longer sold | 1,341 | 382 | 343 | 46 | 15 | 4 | Records → | |
| Tripeptide-2 | Supplement or cosmetic | No clinical trial on record Failed when tested for one use | 47 | 12 | 10 | 0 | 0 | 0 | Records → | |
| Tripeptide-10 Citrulline (Decorinyl) | Supplement or cosmetic | Published trials only 1 clinical trial publication, no phased trial registered Failed when tested for one use | 2 | 2 | 2 | 1 | 0 | 0 | Records → | |
| Tripeptide-29 | Supplement or cosmetic | Published trials only 6 clinical trial publications, no phased trial registered | 45 | 22 | 12 | 6 | 3 | 0 | Records → | |
| Tripeptide-132 | Supplement or cosmetic | No clinical trial on record | 1 | 1 | 1 | 0 | 0 | 0 | Records → | |
| Triptorelin | FDA-approved | Approved in the US | 1,536 | 392 | 257 | 102 | 313 | 16 | Records → | |
| Trofinetide (Daybue) | FDA-approved | Approved in the US | 106 | 64 | 35 | 14 | 14 | 4 | 1 | Records → |
| TUDCA | Supplement or cosmetic | Approved outside the US Italy, Turkey | 1,602 | 217 | 109 | 10 | 44 | 9 | 1 | Records → |
| Tuftsin | Research only | Published trials only 3 clinical trial publications, no phased trial registered | 647 | 165 | 100 | 3 | 0 | 0 | Records → | |
| U | ||||||||||
| UBT251 | Investigational | 17 | 14 | 0 | 0 | 14 | 0 | Records → | ||
| Ularitide | Investigational | 333 | 188 | 107 | 45 | 4 | 0 | Records → | ||
| Urocortin-2 | Research only | Published trials only 5 clinical trial publications, no phased trial registered | 380 | 112 | 50 | 5 | 6 | 0 | Records → | |
| Urolithin A | Supplement or cosmetic | 1,024 | 277 | 177 | 21 | 37 | 2 | 2 | Records → | |
| V | ||||||||||
| Vancomycin (Vancocin) | FDA-approved | Approved in the US | 3,751 | 314 | 174 | 5 | 705 | 26 | 1 | Records → |
| Vasopressin (Vasostrict) | FDA-approved | Approved in the US Failed when tested for 3 uses | 1,279 | 394 | 239 | 45 | 430 | 13 | Records → | |
| Ventfort | Research only | No clinical trial on record | 14 | 1 | 1 | 0 | 0 | 0 | Records → | |
| Vesilute | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Vesugen | Research only | No clinical trial on record | 6 | 3 | 1 | 0 | 0 | 0 | Records → | |
| Vialox (Pentapeptide-3) | Supplement or cosmetic | No clinical trial on record | 2 | 2 | 2 | 0 | 0 | 0 | Records → | |
| Vilon | Research only | Published trials only 3 clinical trial publications, no phased trial registered | 64 | 20 | 12 | 3 | 0 | 0 | Records → | |
| VIP (Vasoactive Intestinal Peptide) | Research only | Phase 3 results posted · NCT04843761 | 72 | 32 | 15 | 5 | 9 | 3 | 1 | Records → |
| Visoluten | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Vitamin B12 | Supplement or cosmetic | Approved in the US by injection only | 1,424 | 349 | 194 | 49 | 794 | 11 | 1 | Records → |
| VK2735 | Investigational | 9 | 9 | 1 | 1 | 8 | 0 | Records → | ||
| Vladonix | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Voclosporin (Lupkynis) | FDA-approved | Approved in the US Failed when tested for 3 uses | 253 | 156 | 65 | 17 | 28 | 10 | Records → | |
| Vosoritide (Voxzogo) | FDA-approved | Approved in the US | 159 | 94 | 56 | 11 | 18 | 3 | Records → | |
| Z | ||||||||||
| Zabopegdutide (DD01) | Investigational | Phase 2 completed, no results posted · NCT06410924 | 5 | 4 | 1 | 1 | 2 | 0 | Records → | |
| Zaloganan (PLG0206) | Investigational | 52 | 20 | 10 | 2 | 2 | 0 | Records → | ||
| Zelenectide pevedotin | Investigational | 17 | 13 | 6 | 1 | 5 | 0 | Records → | ||
| Zhenoluten | Research only | No clinical trial on record | 0 | 0 | 0 | 0 | 0 | 0 | Records → | |
| Ziconotide | FDA-approved | Approved in the US | 432 | 221 | 106 | 16 | 14 | 1 | Records → | |
| Zilucoplan (Zilbrysq) | FDA-approved | Approved in the US Failed when tested for 3 uses | 110 | 72 | 32 | 8 | 19 | 12 | Records → | |
| Zolucatetide (FOG-001) | Investigational | 1 | 1 | 0 | 0 | 1 | 0 | Records → | ||
| Zovaglutide (ZT-002) | Investigational | 11 | 11 | 0 | 0 | 11 | 0 | Records → | ||
What each column means
- Compound
- The peptide's name. Click it to open its page.
- Status
- Where it stands with regulators, such as FDA-approved, investigational or research only. Same label as on its page.
- Furthest stage
- How far it has got toward approval, from ClinicalTrials.gov and approval records. Phase 1 tests safety in a small group. Phase 3 is the large trial that comes before approval.
- Papers and trials indexed
- Everything found that names this compound: published papers from Europe PMC plus studies registered on ClinicalTrials.gov.
- Papers tagged human
- Papers the database labels as involving people. This includes reviews and lab work on human cells, so it runs high.
- Original human papers
- The column to the left, minus reviews and lab work on human cells. The closest count to original research in people, though it can still include case reports and commentary.
- Clinical trial publications
- Published papers that report a clinical trial. The strictest count of human evidence on this page. Red means none.
- Registered trials
- Studies listed on ClinicalTrials.gov that test this compound. A listing alone does not mean the trial finished or reported anything.
- Trials with posted results
- Registered trials that have posted results on ClinicalTrials.gov. Red means none.
- Retraction notices
- Papers on this compound that were later retracted. Blank means none found.
- Records
- Opens the full list of papers and trials for this compound.
Furthest stage is the highest phase of any ClinicalTrials.gov trial in which the compound is the drug being tested, not a comparator. A combined phase 1/2 trial counts as phase 1 and phase 2/3 as phase 2, and withdrawn trials are left out because they never enrolled anyone. Reaching a phase says how far development got, not whether it worked: a phase 3 can fail, and the compound page marks any use that was tested and failed. Approval comes from each compound page and covers at least one use, not every use people take it for. Trials registered only in other registries, such as China's or the EU's, are not read yet.
See also: the research index, the regulatory tracker, and why most peptides have no human evidence.
Common questions
Which compounds have no published clinical trial?
5-Amino-1MQ, 9-ME-BC, 710GO, ABBV-295, Acetyl Hexapeptide-1, Acetyl Hexapeptide-30, Acetyl Hexapeptide-37 (Diffuporine), Acetyl Hexapeptide-38 (Adifyline), Acetyl Tetrapeptide-3, Acetyl Tetrapeptide-5 (Eyeseryl), Acetyl Tetrapeptide-9, Acetyl Tetrapeptide-11, Acetyl Tetrapeptide-15 (Skinasensyl), Adalank, Adamax, Adamax 984, Adamax 1032, Adipotide, AHK-Cu, Amylin 355 (NN9638), AOD-9604, ASC36, ASC37, AT-7687, ATX-304 (O-304), AZD6234, B7-33, BAM15, Berobenatide, BI 3034701, Biotinoyl Tripeptide-1, Bonomarlot, Bonothyrk, BPC-157, BPC-157 + TB-500, BPC-157 + TB-500 + Cartalax, Brenipatide (LY3537031), Bronchogen, Cardiogen, Cartalax, and 126 more in the table below.
Which compound has the most registered trials?
Glucagon (Baqsimi, Gvoke) (1,530), Gonadorelin (GnRH) (1,164) and EPO (Erythropoietin) (1,055).
How many compounds have a trial with posted results?
168 of 429. Most results posted: Dulaglutide (Trulicity) (47), Leuprolide (Lupron) (44), Pasireotide (Signifor) (40), Teriparatide (Forteo) (38) and Daptomycin (Cubicin) (35).
What does "papers tagged human" mean here?
Counted from Europe PMC indexing, not read by a person; human includes reviews and cell work, original studies exclude both. A human tag comes from the indexer's subject headings and can land on analytical, commentary or lab papers that mention people; clinical trial publications is the narrower count.
Which peptides have reached phase 3 without being approved anywhere?
Amycretin, Amylin (amlintide), Apraglutide, Argireline (Acetyl Hexapeptide-8), Avexitide, Berobenatide, Bimagrumab, Bofanglutide (GZR18), Brenipatide (LY3537031), Cagrilintide, CagriSema, Canvuparatide, Carnosine, Cilengitide (EMD 121974), CT-388, Efmedaglutide Alfa (TG103), Eloralintide, Enclomiphene, GB-115, Glepaglutide (Zeydovio), Kisspeptin, Larazotide, MariTide (maridebart cafraglutide), Nelipepimut-S (NeuVax), Nerinetide (NA-1), Nicotinamide Riboside (NR), NMN, Olatorepatide (HS-20094), Oligopeptide-1 (EGF), Omiganan (MBI-226), P140 (forigerimod), Pemvidutide, Petrelintide, Pexiganan, PL9643, Poterepatide (HDM1005), RAY1225 (Bilpatide), Relamorelin, Reltecimod (AB103), Retatrutide, Ribupatide, Rindopepimut (CDX-110), RYZ101 (actinium-225 dotatate), Serelaxin (RLX030), Surotomycin, Survodutide, Tertomotide (GV1001), UBT251, Ularitide, VIP (Vasoactive Intestinal Peptide), VK2735 and Zovaglutide (ZT-002).
Which peptides are approved outside the US but not in it?
Anamorelin (Japan), Atosiban (Tractocile) (European Union, United Kingdom, Switzerland), Beinaglutide (China), Carbetocin (Pabal, Duratocin) (United Kingdom, Canada, Australia, Switzerland), Carperitide (Japan), Cerebrolysin (45+ countries), Cerebroprotein Hydrolysate (China, India), Cortexin (Russia), Ecnoglutide (China), Efpeglenatide (South Korea), Efsubaglutide Alfa (China), Imunofan (Russia), Lumekefamide (Tafalgin) (Russia), Mazdutide (China), Mifamurtide (Mepact) (European Union, United Kingdom), Noopept (Omberacetam) (Russia), P-15 (Osteogenic Cell Binding Peptide) (European Union, Australia, Canada), P11-4 (Oligopeptide-104) (European Union, Switzerland), Pegloxenatide (Fulaimei) (China), Phenibut (Russia), RADA16 (PuraStat) (European Union, Japan, Australia, Canada, Brazil, Mexico, Indonesia, Thailand, Colombia), Retinalamin (Russia), Selank (Russia), Semax (Russia), Somatostatin (Spain, Singapore, Germany, France, Italy, Poland, Austria, Belgium, Cyprus, Czech Republic), Sovateltide (India), Taltirelin (Ceredist) (Japan, South Korea), Thymogen (Russia), Thymopentin (TP-5) (Italy, China), Thymosin Alpha-1 (30+ countries) and TUDCA (Italy, Turkey).
What does "furthest stage" mean?
Furthest stage is the highest phase of any ClinicalTrials.gov trial in which the compound is the drug being tested, not a comparator. A combined phase 1/2 trial counts as phase 1 and phase 2/3 as phase 2, and withdrawn trials are left out because they never enrolled anyone. Reaching a phase says how far development got, not whether it worked: a phase 3 can fail, and the compound page marks any use that was tested and failed. Approval comes from each compound page and covers at least one use, not every use people take it for. Trials registered only in other registries, such as China's or the EU's, are not read yet.